802 related articles for article (PubMed ID: 20146939)
1. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).
Kroh EM; Parkin RK; Mitchell PS; Tewari M
Methods; 2010 Apr; 50(4):298-301. PubMed ID: 20146939
[TBL] [Abstract][Full Text] [Related]
2. An Enhanced Quantitative Reverse Transcription-PCR Approach for Measuring Circulating MicroRNAs.
Tavallaie M; Khafaei M
Methods Mol Biol; 2024; 2745():227-231. PubMed ID: 38060189
[TBL] [Abstract][Full Text] [Related]
3. Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.
Van Roosbroeck K; Bayraktar R; Calin GA
Methods Mol Biol; 2019; 1881():267-276. PubMed ID: 30350212
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling in plasma or serum using quantitative RT-PCR.
Costa MC; Leitão AL; Enguita FJ
Methods Mol Biol; 2014; 1182():121-9. PubMed ID: 25055906
[TBL] [Abstract][Full Text] [Related]
5. Free Circulating miRNAs Measurement in Clinical Settings: The Still Unsolved Issue of the Normalization.
Faraldi M; Gomarasca M; Banfi G; Lombardi G
Adv Clin Chem; 2018; 87():113-139. PubMed ID: 30342709
[TBL] [Abstract][Full Text] [Related]
6. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
[TBL] [Abstract][Full Text] [Related]
7. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
Bell E; Watson HL; Bailey S; Murray MJ; Coleman N
Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
[TBL] [Abstract][Full Text] [Related]
8. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.
Chen X; Ba Y; Ma L; Cai X; Yin Y; Wang K; Guo J; Zhang Y; Chen J; Guo X; Li Q; Li X; Wang W; Zhang Y; Wang J; Jiang X; Xiang Y; Xu C; Zheng P; Zhang J; Li R; Zhang H; Shang X; Gong T; Ning G; Wang J; Zen K; Zhang J; Zhang CY
Cell Res; 2008 Oct; 18(10):997-1006. PubMed ID: 18766170
[TBL] [Abstract][Full Text] [Related]
9. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
10. Direct quantification of circulating miRNAs in different stages of nasopharyngeal cancerous serum samples in single molecule level with total internal reflection fluorescence microscopy.
Ho SL; Chan HM; Ha AW; Wong RN; Li HW
Anal Chem; 2014 Oct; 86(19):9880-6. PubMed ID: 25207668
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Circulating MicroRNAs by Droplet Digital PCR.
Ferracin M; Negrini M
Methods Mol Biol; 2018; 1768():445-457. PubMed ID: 29717458
[TBL] [Abstract][Full Text] [Related]
13. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
[TBL] [Abstract][Full Text] [Related]
14. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
Chung YW; Bae HS; Song JY; Lee JK; Lee NW; Kim T; Lee KW
Int J Gynecol Cancer; 2013 May; 23(4):673-9. PubMed ID: 23542579
[TBL] [Abstract][Full Text] [Related]
15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
16. MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients.
Yilmaz SS; Guzel E; Karatas OF; Yilmaz M; Creighton CJ; Ozen M
Laryngoscope; 2015 Dec; 125(12):E377-81. PubMed ID: 25945817
[TBL] [Abstract][Full Text] [Related]
17. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs: potential biomarkers for common malignancies.
Khoury S; Tran N
Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
Leuenberger N; Saugy M
Adv Exp Med Biol; 2015; 888():401-8. PubMed ID: 26663194
[TBL] [Abstract][Full Text] [Related]
20. Development and application of a novel reverse transcription real-time PCR method for miR-499 quantification.
Zheng W; Di Y; Liu Y; Huang G; Zheng Y; Zhang Y; Fang W
Clin Biochem; 2013 Oct; 46(15):1566-71. PubMed ID: 23872321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
